Sun Pharmaceutical today surged as much as 3 per cent in morning trade on BSE and NSE amid news that the company is likely to enter into a marketing tie up with US drug major Merck & Co.
Shares of Sun Pharma touched Rs 455.90, a jump of 3 per cent over its previous closing price on the Bombay Stock Exchange.
A similar trend was witnessed in National Stock Exchange where the scrip surged by 3 per cent to Rs 454.90 a piece.
The partnership, if announced, would be the second such large scale sales and marketing tie up between a multinational and local drug maker this year after German drug firm Bayer AG announced a joint marketing venture with Ahmedabad-based Cadila Healthcare in January.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.